Status:
COMPLETED
Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)
Lead Sponsor:
National Jewish Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Research Resources (NCRR)
Conditions:
Sleep Apnea, Obstructive
Continuous Positive Airway Pressure
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) is a serious sleep disorder in which a person repeatedly stops breathing or experiences shallow breathing for short periods of time during sleep. The most common treatmen...
Detailed Description
OSA is a common sleep disorder that is characterized by a brief collapse and blockage of the upper airway during sleep. This blockage prevents air from flowing properly into the lungs and causes pause...
Eligibility Criteria
Inclusion
- OSA confirmed by polysomnography (PSG)
- CPAP is the prescribed form of treatment for OSA
- Judged by sleep physician to respond to CPAP
Exclusion
- Apnea/hypoxia index (AHI) less than 15 and no daytime functional symptoms or associated cardiovascular disease
- Diagnosis of another sleep disorder that causes arousals from sleep
- Past treatment for OSA
- Current substance abuse problem
- Diagnosis of a serious medical condition that would interfere with involvement in the study
- History of a major psychiatric disorder, other than depression
- Change in antidepressant medication in the 3 months before study entry
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT00623246
Start Date
December 1 2007
End Date
November 1 2015
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Medical and Research Center
Denver, Colorado, United States, 80206